(Q42609587)

3 November 2017

title

Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors (English)

1 reference

3 November 2017

1 reference

Ménard S

1

1 reference

3 November 2017

Casalini P

2

1 reference

3 November 2017

Tomasic G

3

1 reference

3 November 2017

Pilotti S

4

1 reference

3 November 2017

Cascinelli N

5

1 reference

3 November 2017

Bufalino R

6

1 reference

3 November 2017

Perrone F

7

1 reference

3 November 2017

Longhi C

8

1 reference

3 November 2017

Rilke F

9

1 reference

3 November 2017

Colnaghi MI

10

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

3 November 2017

number of pages

9

1 reference

Breast Cancer Research and Treatment

inferred from page(s)

published in

1 reference

3 November 2017

volume

55

1 reference

3 November 2017

issue

2

1 reference

3 November 2017

page(s)

169-177

1 reference

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Potential immunogenicity of oncogene and tumor suppressor gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

Do we really need prognostic factors for breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Concurrent abnormal expression of ERBB-2, EGFR, and p53 genes and clinical disease progression of breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006262324959

7 January 2021

Identifiers

DOI

10.1023/A:1006262324959

1 reference

Dimensions Publication ID

3 November 2017

1047763314

0 references

1 reference